Description

Mal-VC-PAB-PNP-CDN-A is a drug-Linker conjugates for ADC[1].–Applications-Cancer-programmed cell death-Formula-C51H67N17O20P2-Citation–References-[1]Chen, Zhijian, et al. ANTIBODY-STING AGONIST CONJUGATES AND THEIR USE IN IMMUNOTHERAPY. Patent. US20210015941A1.|[2]Wang Y, et al. Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29(1):754-766. -CASNumber-2640880-35-7-MolecularWeight-1300.13-Compound Purity–SMILES-CC(C)[C@H](NC(CCCCCN1C(C=CC1=O)=O)=O)C(N[C@H](C(NC(C=C2)=CC=C2COC(NCC[C@@H]([C@@H](O3)[C@@H]4N5C=NC6=C5N=C(N)NC6=O)[C@H](O4)COP(O[C@H]7[C@@H](O)[C@H](N(C=N8)C9=C8C(N)=NC=N9)O[C@@H]7COP3(O)=O)(O)=O)=O)=O)CCCNC(N)=O)=O-Research_Area-Cancer-Solubility-10 mM in DMSO-Target-Drug-Linker Conjugates for ADC-Isoform–Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related